KAHR Medical

1 stories about KAHR Medical
ירון פרג מנכל כאהר מדיקל

Cancer Treatment Company KAHR Medical Raises $18 Million

25.02.20|CTech
The company intends to use the funding to advance its immuno-oncology drug candidates, especially its lead product, DSP107, tested for the treatment of solid tumors